Clinical Trial Update: Evaluation of BTX Injections in Treatment of Bruxism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating botulinum toxin injections for the treatment of bruxism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bruxism

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Alexandria University | Conditions: Bruxism | Phase 3 | Status: UNKNOWN